Equities analysts expect HCA Holdings, Inc. (NYSE:HCA) to report sales of $10.71 billion for the current quarter, according to Zacks Investment Research. Nine analysts have made estimates for HCA Holdings’ earnings. The highest sales estimate is $10.86 billion and the lowest is $10.60 billion. HCA Holdings posted sales of $10.27 billion in the same quarter last year, which indicates a positive year over year growth rate of 4.3%. The business is scheduled to announce its next quarterly earnings report on Thursday, October 26th.

On average, analysts expect that HCA Holdings will report full-year sales of $10.71 billion for the current year, with estimates ranging from $42.93 billion to $43.72 billion. For the next fiscal year, analysts forecast that the firm will post sales of $45.50 billion per share, with estimates ranging from $45.13 billion to $46.00 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for HCA Holdings.

HCA Holdings (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.80 by ($0.05). HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The business had revenue of $10.73 billion for the quarter, compared to analysts’ expectations of $10.76 billion. During the same quarter in the prior year, the firm earned $1.66 earnings per share. HCA Holdings’s quarterly revenue was up 4.0% compared to the same quarter last year.

HCA has been the topic of several analyst reports. Robert W. Baird lowered their price target on HCA Holdings from $95.00 to $93.00 and set an “outperform” rating on the stock in a report on Tuesday, August 22nd. ValuEngine downgraded HCA Holdings from a “buy” rating to a “hold” rating in a report on Thursday, September 7th. BMO Capital Markets initiated coverage on HCA Holdings in a report on Monday. They set an “outperform” rating and a $90.00 price target on the stock. Argus assumed coverage on HCA Holdings in a report on Wednesday, June 28th. They set a “buy” rating and a $100.00 price target on the stock. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $95.00 price objective on shares of HCA Holdings in a research note on Wednesday, September 6th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $92.79.

Shares of HCA Holdings (HCA) opened at 76.82 on Wednesday. HCA Holdings has a 1-year low of $67.00 and a 1-year high of $91.03. The firm’s 50-day moving average is $77.65 and its 200 day moving average is $82.18. The stock has a market capitalization of $27.75 billion, a P/E ratio of 10.30 and a beta of 0.62.

In other HCA Holdings news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction on Friday, September 15th. The shares were sold at an average price of $79.87, for a total transaction of $171,720.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 2.90% of the stock is owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. boosted its stake in HCA Holdings by 14.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after buying an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. boosted its stake in HCA Holdings by 35.1% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after buying an additional 320 shares in the last quarter. Atlantic Trust LLC acquired a new stake in HCA Holdings during the second quarter worth $118,000. Lee Financial Co acquired a new stake in HCA Holdings during the second quarter worth $125,000. Finally, Acrospire Investment Management LLC boosted its stake in HCA Holdings by 14.3% during the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after buying an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 73.76% of the company’s stock.

WARNING: “Zacks: Analysts Expect HCA Holdings, Inc. (HCA) Will Post Quarterly Sales of $10.71 Billion” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/10/18/zacks-analysts-expect-hca-holdings-inc-hca-will-post-quarterly-sales-of-10-71-billion.html.

About HCA Holdings

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Holdings (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.